Shareable Research Card

MDT - Medtronic plc Amortization of Intangible Assets

This metric view shows MDT - Medtronic plc amortization of intangible assets history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2025
Latest reported value
$441,000,000

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 23 Jan 2026
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q4 2025.
  • Latest reported value on this page: $441,000,000.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Amortization of Intangible Assets

Ownership report updated

Latest reported amortization of intangible assets: $441,000,000. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

23 Jan 2026

Page type

Metric history

Latest period

Q4 2025

Ownership context was refreshed from SEC Forms 3/4/5 filed on 05 Mar 2026.

Benchmark Context

How Amortization of Intangible Assets compares with peers

Medtronic plc sits in the upper half of the current amortization of intangible assets sample.

Compared with

Compared with 120 companies reporting amortization of intangible assets in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 1.1x the current sample midpoint. Amortization of Intangible Assets is up about 6% versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Dec 2013 to 31 Mar 2026.
  • Nearby companies in this sample: CVS HEALTH Corp and DANAHER CORP /DE/.
  • Current sample position: rank #51 of 120 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

Medtronic plc: Amortization of Intangible Assets

Latest period: Q4 2025. Period end: 23 Jan 2026. Units: USD. Frequency: quarterly and annual.

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

What This Metric Tells You

  • Shows the reported level of amortization of intangible assets over 26 Apr 2013 - 23 Jan 2026.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 60 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.
  • Use the TTM line to smooth quarter-to-quarter noise.

Compare This Metric Across Companies

Compare latest available Amortization of Intangible Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Medtronic plc appears at rank #51 in the latest comparison sample.

Rank Company Latest value Reported period Next step
1 AbbVie Inc. (abbv) $7,377,000,000 Year - 31 Dec 2025 Open AbbVie Inc. Amortization of Intangible Assets
2 Warner Bros. Discovery, Inc. (wbd) $4,605,000,000 Year - 31 Dec 2025 Open Warner Bros. Discovery, Inc. Amortization of Intangible Assets
3 AT&T INC. (t) $4,288,000,000 Year - 31 Dec 2021 Open AT&T INC. Amortization of Intangible Assets
4 Merck & Co., Inc. (mrk) $2,800,000,000 Year - 31 Dec 2025 Open Merck & Co., Inc. Amortization of Intangible Assets
5 GILEAD SCIENCES, INC. (gild) $2,400,000,000 Year - 31 Dec 2025 Open GILEAD SCIENCES, INC. Amortization of Intangible Assets
6 Broadcom Inc. (avgo) $1,969,000,000 Quarter - 01 Feb 2026 Open Broadcom Inc. Amortization of Intangible Assets

Metric Details

Metric
Amortization of Intangible Assets (AmortizationOfIntangibleAssets)
Taxonomy
us-gaap
Units tracked
USD
Frequency coverage
quarterly and annual
History range
26 Apr 2013 - 23 Jan 2026
Facts on this page
60
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

Medtronic plc Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,927,000,000 $441,000,000 +$25,000,000 +6% 25 Oct 2025 23 Jan 2026 10-Q 24 Feb 2026 2026 Q3
Q3 2025 $1,902,000,000 $463,000,000 +$50,000,000 +12% 26 Jul 2025 24 Oct 2025 10-Q 25 Nov 2025 2026 Q2
Q2 2025 $1,852,000,000 $459,000,000 +$45,000,000 +11% 26 Apr 2025 25 Jul 2025 10-Q 26 Aug 2025 2026 Q1
Q1 2025 $1,807,000,000 $564,000,000 +$144,000,000 +34% 25 Jan 2025 25 Apr 2025 10-K 20 Jun 2025 2025 FY
Q4 2024 $1,663,000,000 $416,000,000 -$3,000,000 -0.72% 26 Oct 2024 24 Jan 2025 10-Q 24 Feb 2026 2026 Q3
Q3 2024 $1,666,000,000 $413,000,000 -$12,000,000 -2.8% 27 Jul 2024 25 Oct 2024 10-Q 25 Nov 2025 2026 Q2
Q2 2024 $1,678,000,000 $414,000,000 -$15,000,000 -3.5% 27 Apr 2024 26 Jul 2024 10-Q 26 Aug 2025 2026 Q1
Q1 2024 $1,693,000,000 $420,000,000 -$3,000,000 -0.71% 27 Jan 2024 26 Apr 2024 10-K 20 Jun 2025 2025 FY
Q4 2023 $1,696,000,000 $419,000,000 -$12,000,000 -2.8% 28 Oct 2023 26 Jan 2024 10-Q 25 Feb 2025 2025 Q3
Q3 2023 $1,708,000,000 $425,000,000 +$4,000,000 +0.95% 29 Jul 2023 27 Oct 2023 10-Q 26 Nov 2024 2025 Q2
Q2 2023 $1,704,000,000 $429,000,000 +$6,000,000 +1.4% 29 Apr 2023 28 Jul 2023 10-Q 27 Aug 2024 2025 Q1
Q1 2023 $1,698,000,000 $423,000,000 -$11,000,000 -2.5% 28 Jan 2023 28 Apr 2023 10-K 20 Jun 2025 2025 FY
Q4 2022 $1,709,000,000 $431,000,000 -$1,000,000 -0.23% 29 Oct 2022 27 Jan 2023 10-Q 27 Feb 2024 2024 Q3
Q3 2022 $1,710,000,000 $421,000,000 -$10,000,000 -2.3% 30 Jul 2022 28 Oct 2022 10-Q 30 Nov 2023 2024 Q2
Q2 2022 $1,720,000,000 $423,000,000 -$13,000,000 -3% 30 Apr 2022 29 Jul 2022 10-Q 31 Aug 2023 2024 Q1
Q1 2022 $1,733,000,000 $434,000,000 -$13,000,000 -2.9% 29 Jan 2022 29 Apr 2022 10-K 20 Jun 2024 2024 FY
Q4 2021 $1,746,000,000 $432,000,000 -$21,000,000 -4.6% 30 Oct 2021 28 Jan 2022 10-Q 01 Mar 2023 2023 Q3
Q3 2021 $1,767,000,000 $431,000,000 -$12,000,000 -2.7% 31 Jul 2021 29 Oct 2021 10-Q 01 Dec 2022 2023 Q2
Q2 2021 $1,779,000,000 $436,000,000 -$4,000,000 -0.91% 01 May 2021 30 Jul 2021 10-Q 01 Sep 2022 2023 Q1
Q1 2021 $1,783,000,000 $447,000,000 +$8,000,000 +1.8% 30 Jan 2021 30 Apr 2021 10-K 22 Jun 2023 2023 FY
Q4 2020 $1,775,000,000 $453,000,000 +$17,000,000 +3.9% 31 Oct 2020 29 Jan 2021 10-Q 03 Mar 2022 2022 Q3
Q3 2020 $1,758,000,000 $443,000,000 +$2,000,000 +0.45% 01 Aug 2020 30 Oct 2020 10-Q 02 Dec 2021 2022 Q2
Q2 2020 $1,756,000,000 $440,000,000 $0 0% 25 Apr 2020 31 Jul 2020 10-Q 02 Sep 2021 2022 Q1
Q1 2020 $1,756,000,000 $439,000,000 +$2,000,000 +0.46% 25 Jan 2020 24 Apr 2020 10-K 23 Jun 2022 2022 FY
Q4 2019 $1,754,000,000 $436,000,000 $0 0% 26 Oct 2019 24 Jan 2020 10-Q 05 Mar 2021 2021 Q3
Q3 2019 $1,754,000,000 $441,000,000 -$4,000,000 -0.9% 27 Jul 2019 25 Oct 2019 10-Q 03 Dec 2020 2021 Q2
Q2 2019 $1,758,000,000 $440,000,000 -$6,000,000 -1.3% 27 Apr 2019 26 Jul 2019 10-Q 03 Sep 2020 2021 Q1
Q1 2019 $1,764,000,000 $437,000,000 -$11,000,000 -2.5% 26 Jan 2019 26 Apr 2019 10-K 25 Jun 2021 2021 FY
Q4 2018 $1,775,000,000 $436,000,000 -$25,000,000 -5.4% 27 Oct 2018 25 Jan 2019 10-Q 28 Feb 2020 2020 Q3
Q3 2018 $1,800,000,000 $445,000,000 -$15,000,000 -3.3% 28 Jul 2018 26 Oct 2018 10-Q 03 Dec 2019 2020 Q2
Q2 2018 $1,815,000,000 $446,000,000 -$8,000,000 -1.8% 28 Apr 2018 27 Jul 2018 10-Q 30 Aug 2019 2020 Q1
Q1 2018 $1,823,000,000 $448,000,000 -$48,000,000 -9.7% 27 Jan 2018 27 Apr 2018 10-K 19 Jun 2020 2020 FY
Q4 2017 $1,871,000,000 $461,000,000 -$36,000,000 -7.2% 28 Oct 2017 26 Jan 2018 10-Q 01 Mar 2019 2019 Q3
Q3 2017 $1,907,000,000 $460,000,000 -$40,000,000 -8% 29 Jul 2017 27 Oct 2017 10-Q 29 Nov 2018 2019 Q2
Q2 2017 $1,947,000,000 $454,000,000 -$33,000,000 -6.8% 29 Apr 2017 28 Jul 2017 10-Q 31 Aug 2018 2019 Q1
Q1 2017 $1,980,000,000 $496,000,000 +$13,000,000 +2.7% 28 Jan 2017 28 Apr 2017 10-K 21 Jun 2019 2019 FY
Q4 2016 $1,967,000,000 $497,000,000 +$13,000,000 +2.7% 29 Oct 2016 27 Jan 2017 10-Q 02 Mar 2018 2018 Q3
Q3 2016 $1,954,000,000 $500,000,000 +$17,000,000 +3.5% 30 Jul 2016 28 Oct 2016 10-Q 04 Dec 2017 2018 Q2
Q2 2016 $1,937,000,000 $487,000,000 +$6,000,000 +1.2% 30 Apr 2016 29 Jul 2016 10-Q 01 Sep 2017 2018 Q1
Q1 2016 $1,931,000,000 $483,000,000 +$15,000,000 +3.2% 30 Jan 2016 29 Apr 2016 10-K 22 Jun 2018 2018 FY
Q4 2015 $1,916,000,000 $484,000,000 +$395,000,000 +444% 31 Oct 2015 29 Jan 2016 10-Q 03 Mar 2017 2017 Q3
Q3 2015 $1,521,000,000 $483,000,000 +$394,000,000 +443% 01 Aug 2015 30 Oct 2015 10-Q 05 Dec 2016 2017 Q2
Q2 2015 $1,127,000,000 $481,000,000 +$394,000,000 +453% 25 Apr 2015 31 Jul 2015 10-Q 07 Sep 2016 2017 Q1
Q1 2015 $733,000,000 $468,000,000 24 Jan 2015 24 Apr 2015 10-K 27 Jun 2017 2017 FY
Q4 2014 $89,000,000 25 Oct 2014 23 Jan 2015 10-Q 09 Mar 2016 2016 Q3
Q3 2014 $89,000,000 26 Jul 2014 24 Oct 2014 10-Q 09 Dec 2015 2016 Q2
Q2 2014 $87,000,000 26 Apr 2014 25 Jul 2014 10-Q 09 Sep 2015 2016 Q1

Medtronic plc Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,807,000,000 +$114,000,000 +6.7% 27 Apr 2024 25 Apr 2025 10-K 20 Jun 2025 2025 FY
2023 $1,693,000,000 -$5,000,000 -0.29% 29 Apr 2023 26 Apr 2024 10-K 20 Jun 2025 2025 FY
2022 $1,698,000,000 -$35,000,000 -2% 30 Apr 2022 28 Apr 2023 10-K 20 Jun 2025 2025 FY
2021 $1,733,000,000 -$50,000,000 -2.8% 01 May 2021 29 Apr 2022 10-K 20 Jun 2024 2024 FY
2020 $1,783,000,000 +$27,000,000 +1.5% 25 Apr 2020 30 Apr 2021 10-K 22 Jun 2023 2023 FY
2019 $1,756,000,000 -$8,000,000 -0.45% 27 Apr 2019 24 Apr 2020 10-K 23 Jun 2022 2022 FY
2018 $1,764,000,000 -$59,000,000 -3.2% 28 Apr 2018 26 Apr 2019 10-K 25 Jun 2021 2021 FY
2017 $1,823,000,000 -$157,000,000 -7.9% 29 Apr 2017 27 Apr 2018 10-K 19 Jun 2020 2020 FY
2016 $1,980,000,000 +$49,000,000 +2.5% 30 Apr 2016 28 Apr 2017 10-K 21 Jun 2019 2019 FY
2015 $1,931,000,000 +$1,198,000,000 +163% 25 Apr 2015 29 Apr 2016 10-K 22 Jun 2018 2018 FY
2014 $733,000,000 +$384,000,000 +110% 26 Apr 2014 24 Apr 2015 10-K 27 Jun 2017 2017 FY
2013 $349,000,000 +$18,000,000 +5.4% 27 Apr 2013 25 Apr 2014 10-K 28 Jun 2016 2016 FY
2012 $331,000,000 28 Apr 2012 26 Apr 2013 10-K 23 Jun 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .